Gene therapy research for kidney diseases
Authors:
- 1 September 2019
- journal article
- review article
- Published by American Physiological Society in Physiological Genomics
- Vol. 51 (9) , 449-461
Abstract
A resurgence in the development of newer gene therapy systems has led to recent successes in the treatment of B cell cancers, retinal degeneration and neuromuscular atrophy. Gene therapy offers the ability to treat the patient at the root cause of their malady by restoring normal gene function and arresting the pathological progression of their genetic disease. The current standard of care for most genetic diseases is based upon the symptomatic treatment with polypharmacy while minimizing any potential adverse effects attributed to the off-target and drug-drug interactions on the target or other organs. In the kidney, however, the development of gene therapy modifications to specific renal cells has lagged far behind those in other organ systems. Some positive strides in the past few years provide continued enthusiasm to invest the time and effort in the development of new gene therapy vectors for medical intervention to treat kidney diseases. This mini-review will systematically describe the pros and cons of the most commonly tested gene therapy vector systems derived from adenovirus, retrovirus, and adeno-associated virus and provide insight about their potential utility as a therapy for various types of genetic diseases in the kidney.Keywords
This publication has 102 references indexed in Scilit:
- Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic IntegrationPLOS ONE, 2013
- Comparison of the transduction efficiency of tyrosine‐mutant adeno‐associated virus serotype vectors in kidneyClinical and Experimental Pharmacology and Physiology, 2012
- Preclinical Dose-Finding Study With a Liver-Tropic, Recombinant AAV-2/8 Vector in the Mouse Model of GalactosialidosisMolecular Therapy, 2012
- The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus SerotypesJournal of Virology, 2011
- Adeno-Associated Virus-Mediated Gene Transfer to Renal Tubule Cells via a Retrograde Ureteral ApproachNephron Extra, 2011
- Lentiviral-Human Heme Oxygenase Targeting Endothelium Improved Vascular Function in Angiotensin II Animal Model of HypertensionHuman Gene Therapy, 2011
- Combined Paracrine and Endocrine AAV9 mediated Expression of Hepatocyte Growth Factor for the Treatment of Renal FibrosisMolecular Therapy, 2010
- Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia–reperfusion injuryKidney International, 2009
- Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse modelVirology, 2009
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006